期刊文献+

脑梗死与对氧磷酶1基因192G/A位点多态性的关系 被引量:3

Relationship of cerebral infarction with paraoxonase 1 gene 192G/A polymorphism
原文传递
导出
摘要 目的:评估脑梗死患者对氧磷酶1(paraoxonase 1,PON1)的基因192G/A多态性与脑梗死间的关系。方法:采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法分析295例脑梗死患者(脑梗死组)及117名正常对照者(对照组)的PON1基因192G/A多态性。结果:PON1基因192G/A多态性在对照组和脑梗死组中的GG型、GA型和AA型基因型分布分别为36.75%、50.43%、12.82%和28.14%、50.85%、21.02%。G、A等位基因分布在对照组和脑梗死组中分别为61.97%、38.03%和53.56%、46.44%。经检验,PON1基因192G/A位点基因型频率在2组人群中的分布差异无统计学意义(P>0.05),而等位基因频率在2组人群中的分布差异有统计学意义(P<0.05),脑梗死组的等位基因A与对照组比较,其比数比为1.2210,95%可信区间(95%CI)为1.0147~1.4793。结论:PON1基因192G/A多态性可能与脑梗死有关。 Objective To investigate the relationship of cerebral infarction with paraoxonase 1(PON1)gene 192G/A polymorphism.Methods Genotypes of PON1 gene 192G/A were determined in 295 cerebral infarction patients and 117 controls by using polymerase chain reaction-restriction fragment length polymorphism(PCR-RFLP) method.Results The distributions of GG,GA and AA genotypes of PON1 gene were 36.75%,50.43% and 12.82% in control group and 28.14%,50.85% and 21.02% in cerebral infarction group,respectively.The frequencies of allelic G and A were 61.97% and 38.03% in control group and 53.56% and 46.44% in cerebral infarction group,respectively.The difference of genotype frequency of PON1 192G/A was not statistically significant(P0.05) but that of allelic frequency was statistically significant(P0.05) between the two groups.Odds ratio of allele A in cerebral infarction group was 1.2210 with 95% confidence interval 1.0147-1.4793 as compared with the control group.Conclusions PON1 gene 192G/A polymorphism might have relation with cerebral infarction.
出处 《诊断学理论与实践》 2011年第1期50-54,共5页 Journal of Diagnostics Concepts & Practice
关键词 对氧磷酶1 脑梗死 多态性 Paraoxonase 1 Cerebral infarction Polymorphism
  • 相关文献

参考文献21

  • 1Primo-Parmo SL, Sorenson RC, Teiber J, et al. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family [J]. Genomics,1996,33(3):498-507.
  • 2Mackness MI, Hallam SD, Peard T, et al. The separation of sheep and human serum "A"-esterase activity into the lipoprotein fraction by uItracentrifugation [J]. Comp Biochem Physiol B,1985,82(4):675-677.
  • 3Reddy ST, Wadleigh DJ, Grijalva V, et al. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids[J]. Arterioscler Thromb Vasc Biol,2001,21 (4):542-547.
  • 4Mochizuki H, Scherer SW, Xi T, et al. Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence [J]. Gene, 1998,213(1-2):149-157.
  • 5Draganov DI, La Du BN. Pharmacogenetics of paraoxonases: a brief review [J]. Naunyn Schmiedebergs Arch Pharmacol,2004,369(1):78-88.
  • 6Mackness MI, Mackness B, Durrington PN, et al. Paraoxonase and coronary heart disease [J]. Curr Opin Lipidol, 1998,9(4):319-324.
  • 7Gluba A, Pietrucha T, Banach M, et al. The role of polymorphisms within paraoxonases (192 Gln/Arg in PON1 and 311Ser/Cys in PON2) in the modulation of cardiovas- cular risk: a pilot study [J]. Angiology,2010,61 (2):157- 165.
  • 8倪培华,应雅韵,张洁,金磊.肝脂酶启动子250 G/A多态性与血脂的关系[J].检验医学,2005,20(6):565-570. 被引量:16
  • 9Mackness MI, Mackness B, Durrington PN. Paraoxonase and coronary heart disease [J]. Atheroscler Suppl,2002,3 (4):49-55.
  • 10Bhattacharyya T, Nicholls S J, Topoi E J, et al. Relatioship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk[J]. JAMA,2008,299(11): 1265-1276.

二级参考文献20

  • 1De oiveirae Silva ER, Kong M, Han Z, et al. Metabolic and genetic determinants of HDL metabolism and hepatic lipase activity in normolipidemic females[J]. J Lipid Res, 1999,40:1211-1221.
  • 2Pihlajamaki J, Karjalainen L, Karhapaa P, et al. G250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hypefiidemia[J]. Arterioscler Thromb Vasc Biol,2000,20:1789-1795.
  • 3De Andrade FM, Silveira FR, Arsand M, et al. Association between-250 G/A potymorphism of the hepatic lipase gene promoter and coronary artery disease and HDL-C levels in a Southern Brazilian[J]. Clin Genet, 2004,65 : 390-395.
  • 4Juo SHK, Han Z, Smith JD, et al. Promoter polymorphisms of hepatic lipase gene influence HDL2 but not HDL3 in African American men: CARDIA study[J].J Lipid Res. 2001, 42:258-264.
  • 5Su Z, Zhang S, Daniel W, et al. A novel allele in the promoter of the hepatic lipaseis associated with increased concentration of HDL-C and decreased promoter activity[J]. J Lipid Res,2002,43:1595-1601.
  • 6Dolittle M, Wong H, Davis RC. Synthesis of hepatic lipase in liver and extrahepatic tissue[J]. J Lipid Res, 1987,28:1326-1334.
  • 7Goldberg IJ . Association of plasma lipoprotein with postheparin lipase activities[J]. J Clin Invest, 1986,78: 1523-1528.
  • 8Newnham HH, Hopkins GJ, Devlin S, et al. Lipoprotein lipase prevents the hepatic lipase-induced reduction in particle size of high density lipoproteins during incubation of human plasma[J]. Atherosclerosis, 1990, 82:167-176.
  • 9Jansen H, Chu G, Ehnholm C, et al. The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCⅢ: B- European Atherosclerosis Research Study (EARS) Ⅱ[J]. Arterioscler Thromb Vasc Biol, 1999, 19: 303-308.
  • 10Murtomaki S, Tahvanainen E, AntikainenM, et al.Hepatic lipase gene polymorphisms influence plasma HDL levels. Results from Finnish EARS participants.European atherosclerosis research study[J]. Arterioscler Thromb Vase Biol, 1997,17 : 1879-1884.

共引文献15

同被引文献50

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部